Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01442298
Other study ID # 2007/757-31/1-4
Secondary ID
Status Completed
Phase N/A
First received September 2, 2011
Last updated September 27, 2011
Start date October 2008
Est. completion date October 2010

Study information

Verified date September 2011
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority Sweden: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The use of bloodless field is a helpful and important method in orthopedic surgery. The surgery can be done without interrupting bleedings, while keeping an exact overlook of the anatomy. However the method is not without risks, and complications of various kind may occur. One of the most important factors to minimise the risk of complications, is to keep the lowest possible cuff pressure. Previous electromyography (EMG) studies have indicated neuromuscular abnormalities after bloodless field among many patients which may lead to a prolonged rehabilitation period since they cause a postoperative weakness in the muscles. Although in these studies an unnecessary high tourniquet pressures were used and the EMG tests were made 6 weeks and 6 months after the surgery.

With today's demand for fast rehabilitation, there is a need for better knowledge if lower tourniquet pressure in bloodless field surgery may lead to less neuromuscular abnormalities.

Limb Occlusion Pressure (LOP) is the tourniquet cuff pressure required to occlude the blood flow. It accounts for a patients limb and vessel characteristics and the type and fit of the tourniquet cuff. The method has developed and is now simplified, by using an automatic (plethysmographic) sensor placed on the second toe on the involved limb, and after administration of anaesthesia, and immediately before limb preparation and draping it measures the limb occlusion pressure.

When surgery starts, the cuff is inflated again; plus a safety margin based on the LOP pressure measured. The LOP method is still rarely used it has been seen as difficult and time consuming.

The primary aim of this study is to investigate whether you can reduce the used tourniquet pressure with the new LOP measurement technique and still have a adequate bloodless field; and if this will lead to any clinical difference regarding postoperative pain. The secondary aim is to investigate the difference between the test groups concerning muscle function and wound healing and if these are remaining and of clinical importance. The third aim is to study how common neuromuscular abnormalities are after the use of bloodless field with lower cuff pressures and if there are any differences between the standard method and the LOP method.


Recruitment information / eligibility

Status Completed
Enrollment 164
Est. completion date October 2010
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group N/A to 75 Years
Eligibility Inclusion Criteria:

- Planned for total knee arthroplasty in bloodless field

- 75 year or younger

Exclusion Criteria:

- Patients unable to read and understand Swedish

- Systolic blood pressure over 200 mmHg and a girth of the thigh over 78 cm was excluded.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Limb occlusion pressure (LOP)
The tourniquet cuff pressure were decided by measurement of limb occlusion pressure (LOP) using an automated photo plethysmographic sensor connected to a ATS 3000 tourniquet apparatus (Zimmer Sweden Inc®).
conventional measurement method
Standard method at our department, the tourniquet cuff pressure was based on the patient's systolic blood pressure and a margin that were decided by the surgeon.

Locations

Country Name City State
Sweden Department of clinical science and education, Södersjukhuset Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Charlotta Olivecrona

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cuff pressure (mmHg) For patients in the control group the tourniquet cuff pressure was based on the patient's systolic blood pressure and a margin that were decided by the surgeon. In the LOP group the tourniquet cuff pressure were decided by measurement of limb occlusion pressure (LOP) by using an automated photo plethysmographic sensor connected to a ATS 3000 tourniquet apparatus participantswill be followed for the duration of hospital stay , an expected avarage of 4-5 days No
Primary Quality of bloodless field Direct after surgery the surgeon rated the quality of bloodless fiels on a visual analog scale (VAS) particpants will be followed for the duration of the hospital stay, an expected avarage of 4-5 days No
Secondary Postoperative pain The patients filled in the modified WOMAC scale daily during their hospital stay. The WOMAC is a self -administered and validated health status instrument with 3 domains i.e. pain , physical function and stiffness.A wound control was performed by a ward nurse at discharged. The functional assessment included measurement of the range of motion of the knee joint and a straight leg lifting test (with 1kg weigth) and was performed at third postoperative day by an independent physiotherapist. All patients were followed up two months postoperatively (wound, ROM and WOMAC). The participants were followed daily during their hospital stay (4-5 days) and at the two months follow up after surgery No
Secondary Range of motion (ROM) The participants were examined at third postoperative day and at the two months follow up after surgery No
Secondary Postoperative wound complications The participants were examined at discharged (day 4 or 5 postoperatively) and at the two months follow up after surgery No
Secondary EMG/EnEG Participans were examined day three and two months postoperatively No
See also
  Status Clinical Trial Phase
Completed NCT02043132 - Tranexamic Acid in Reverse Total Shoulder Arthroplasty Phase 2/Phase 3
Recruiting NCT02255331 - Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity
Completed NCT02774174 - The Evaluation of the METS™ Proximal Humeral System
Withdrawn NCT02054936 - Evaluation of Wound Drainage After Knee or Hip Arthroplasty Phase 4
Recruiting NCT01542580 - A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee
Completed NCT01882751 - In Vivo Comparison of Knee Kinematics for Subjects Implanted With Either a ConforMIS or Traditional Knee Implant
Completed NCT02598700 - Correlation of Spinopelvic Parameters and Acetabular Cup Orientation
Completed NCT01820611 - Arcos Revision Stem: Evaluation of Clinical Performance
Completed NCT01514318 - Encore Revelation Hip Stem N/A
Completed NCT02124031 - Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR) N/A
Completed NCT01373112 - Articulating Versus Static Antibiotic Loaded Spacers for the Treatment of Prosthetic Knee Infection N/A
Completed NCT01373099 - Study of Antibiotic Spacer Design to Treat Infection After Hip Replacement N/A